Alazami syndrome
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (December 2024) |
Alazami syndrome is a rare autosomal recessive genetic disorder characterized by short stature, severe mental retardation, speech delay, skeletal deformities, intellectual disability, and distinctive facial features (facial dysmorphisms). Facial features include underdevelopment of the cheekbones, deep-set eyes, broad nose and an enlargement at the corners of the mouth (macrostomia). Skeletal deformities include scoliosis and mild epiphyseal changes in the first bones of the fingers (proximal phalanges), but no severe hip dislocation.[1][2] It was first described by Alazami et al in 2012. The syndrome was presented by a Saudi Arabian family with primordial dwarfism syndrome with LARP7 gene variations.[3] Some affected patients show the lack of voluntary coordination of muscle movements (Ataxia), manifested as a clumsy walking pattern, with frequent trips or falls.[4]
Causes
[edit]The genetic cause of the syndrome is the deletion of LARP7 gene (La Ribonucleoprotein 7)[5] located on chromosome 4q25. The gene expresses a small nuclear ribonucleoprotein that hinders a transcription factor required for resuming transcription by RNA polymerase II enzyme.[6] LARP7 loss-of-function mutations in humans suffer from primordial dwarfism, intellectual disabilities, and facial characteristics changes. Several Alazami syndrome patients show a reduced telomerase activity and very short lymphocyte telomeres.[7] Eventhough thyroid cancer is rare among children and adolescents, those with this disease are LARP7 variants and have Alazami syndrome and tumor susceptibility.[8]
References
[edit]- ^ Bajafar, A.; Rifai, F.; Al-Said, Y.; Cupler, E. (October 15, 2019). "Alazami syndrome due to LARP7 gene mutation: Expanding the phenotype". Journal of the Neurological Sciences. 405: 272–273. doi:10.1016/j.jns.2019.10.1326. S2CID 209478208 – via www.jns-journal.com.
- ^ https://www.malacards.org/card/alazami_syndrome
- ^ Wojcik, M. H.; Linnea, K.; Stoler, J. M.; Rappaport, L. (2019). "Updating the neurodevelopmental profile of Alazami syndrome: illustrating the role of developmental assessment in rare genetic disorders - PMC". American Journal of Medical Genetics. Part A. 179 (8): 1565–1569. doi:10.1002/ajmg.a.61189. PMC 6663627. PMID 31074943.
- ^ https://www.rarechromo.org/media/singlegeneinfo/Single%20Gene%20Disorder%20Guides/Alazami%20Syndrome%20QFN.pdf
- ^ "Alazami Syndrome - CAGS". cags.org.ae.
- ^ Das, Sweta; Godbole, Koumudi; Abraham, Suneetha Susan Cleave; Ganesan, Paramasivam; Kamdar, Payal; Danda, Sumita (May 8, 2021). "Alazami syndrome: Report of three Indian patients with phenotypic spectrum from adolescence to adulthood". American Journal of Medical Genetics. Part A. 185 (5): 1606–1609. doi:10.1002/ajmg.a.62118. PMID 33569879. S2CID 231883626 – via PubMed.
- ^ Hasler, Daniele; Meduri, Rajyalakshmi; Bąk, Maciej; Lehmann, Gerhard; Heizinger, Leonhard; Wang, Xin; Li, Zhi-Tong; Sement, François M.; Bruckmann, Astrid; Dock-Bregeon, Anne-Catherine; Merkl, Rainer; Kalb, Reinhard; Grauer, Eva; Kunstmann, Erdmute; Zavolan, Mihaela; Liu, Mo-Fang; Fischer, Utz; Meister, Gunter (March 5, 2020). "The Alazami Syndrome-Associated Protein LARP7 Guides U6 Small Nuclear RNA Modification and Contributes to Splicing Robustness". Molecular Cell. 77 (5): 1014–1031.e13. doi:10.1016/j.molcel.2020.01.001. PMID 32017898. S2CID 211035370.
- ^ Ivanovski, Ivan; Caraffi, Stefano Giuseppe; Magnani, Elisa; Rosato, Simonetta; Pollazzon, Marzia; Matalonga, Leslie; Piana, Simonetta; Nicoli, Davide; Baldo, Chiara; Bernasconi, Sergio; Frasoldati, Andrea; Zuffardi, Orsetta; Garavelli, Livia (February 8, 2020). "Alazami syndrome: the first case of papillary thyroid carcinoma". Journal of Human Genetics. 65 (2): 133–141. doi:10.1038/s10038-019-0682-5. PMID 31656314. S2CID 254110136 – via www.nature.com.